Adenomyosis (ADS)
Conditions
Interventions
Experimental Group:Hongteng Xiaoliu Formula granules, 1 packet twice daily for 3 months
Control Group:Sanjie Zhentong Capsules, 4 capsules three times daily for 3 months
Sponsors
Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Eligibility
Sex/Gender
Female
Age
20 Years to 50 Years
Inclusion criteria
Inclusion criteria: (1) Clinically diagnosed with adenomyosis confirmed by postoperative pathology; (2) Female aged 20-50 years; (3) Underwent uterus-preserving lesion resection; (4) Complains of dysmenorrhea; (5) Non-pregnant and premenopausal.
Exclusion criteria
Exclusion criteria: (1) No histopathological confirmation or inconsistent diagnosis; (2) Complicated with ovarian or deep infiltrating endometriosis; (3) Misdiagnosed as uterine adenomyoma or fibroids; (4) Bilateral oophorectomy performed; (5) Premenopausal or perimenopausal status.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Dysmenorrhea Symptom Scoring; | — |
Secondary
| Measure | Time frame |
|---|---|
| TCM syndrome score;Menstrual Blood Loss Chart Score;Self-Rating Anxiety Scale (SAS);Self-Rating Depression Scale Score;Quality of Life Assessment Scale;Serum indicators (estrogen, tumor markers, hemoglobin);Transvaginal Ultrasound; | — |
Countries
China
Contacts
Public ContactQian Lin
Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Outcome results
None listed